Pathogenesis of Prediabetes: Role of the Liver in Isolated Fasting Hyperglycemia and Combined Fasting and Postprandial Hyperglycemia
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
CONTEXT: People with prediabetes are at high risk of developing diabetes. OBJECTIVE: The objective of this study was to determine the pathogenesis of fasting and postprandial hyperglycemia in prediabetes. DESIGN: Glucose production, gluconeogenesis, glycogenolysis, and glucose disappearance were measured before and during a hyperinsulinemic clamp using [6,6-(2)H2]glucose and the deuterated water method corrected for transaldolase exchange. SETTING: The study was conducted at the Mayo Clinic Clinical Research Unit. PARTICIPANTS: Subjects with impaired fasting glucose (IFG)/normal glucose tolerance (NGT) (n = 14), IFG/impaired glucose tolerance (IGT) (n = 18), and normal fasting glucose (NFG)/NGT (n = 16) were studied. INTERVENTION: A hyperinsulinemic clamp was used. OUTCOME MEASURES: Glucose production, glucose disappearance, gluconeogenesis, and glycogenolysis were measured. RESULTS: Fasting glucose production was higher (P < .0001) in subjects with IFG/NGT than in those with NFG/NGT because of increased rates of gluconeogenesis (P = .003). On the other hand, insulin-induced suppression of glucose production, gluconeogenesis, glycogenolysis, and stimulation of glucose disappearance all were normal. Although fasting glucose production also was increased (P = .0002) in subjects with IFG/IGT, insulin-induced suppression of glucose production, gluconeogenesis, and glycogenolysis and stimulation of glucose disappearance were impaired (P = .005). CONCLUSIONS: Fasting hyperglycemia is due to excessive glucose production in people with either IFG/NGT or IFG/IGT. Both insulin action and postprandial glucose concentrations are normal in IFG/NGT but abnormal in IFG/IGT. This finding suggests that hepatic and extrahepatic insulin resistance causes or exacerbates postprandial glucose intolerance in IFG/IGT. Elevated gluconeogenesis in the fasting state in IFG/NGT and impaired insulin-induced suppression of both gluconeogenesis and glycogenolysis in IFG/IGT suggest that alteration in the regulation of these pathways occurs early in the evolution of type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Whilst it is firmly established that pathological pancreatic function and peripheral tissue insulin resistance are central to T2D aetiology/pathogenesis, there is increasing evidence that other extrapancreatic pathologies may contribute.30,191,192”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [191]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“However, research evidence over the last few decades suggests that some of these pathologies manifest during the prediabetic phase and is possibly therefore involved in both the disease pathogenesis and aetiology.191,192”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [191]
The cited source says what the claim attributes to it.
In the citing paper
“Whilst it is firmly established that pathological pancreatic function and peripheral tissue insulin resistance are central to T2D aetiology/pathogenesis, there is increasing evidence that other extrapancreatic pathologies may contribute.30,191,192”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [191]
In the citing paper
“For example, skin and liver pathology can manifest during the prediabetic stage, and even in individuals with metabolic syndrome before islet beta-cell dysfunction occurs.191,196”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [191]
In the citing paper
“Interestingly, insulin-induced suppression of gluconeogenesis and glycogenolysis has also been shown to be impaired in individuals with prediabetes, suggesting that altered liver function is an important component during the initial stages of T2D pathology.191”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [191]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measurement of Size and Turnover Rate of Body Glucose Pool by the Isotope Dilution Method
Steele, R., Wall, J. S., de Bodo, R. C., & Altszuler, N. (1956) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1956.187.1.15 · Cited by 816
Dose-response characteristics for effects of insulin on production and utilization of glucose in man
Rizza, R. A., Mandarino, L. J., & Gerich, J. E. (1981) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1981.240.6.e630 · Cited by 703
Self-citationThe natural history of impaired glucose tolerance in the Pima Indians
Saad, M. F., Knowler, W. C., Pettitt, D. J., Nelson, R. G., Mott, D. M., & Bennett, P. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812083192302 · Cited by 413
Tripathy, D., Carlsson, M., Almgren, P., Isomaa, B., Taskinen, M. R., Tuomi, T., & Groop, L. C. (2000) · Diabetes · doi:10.2337/diabetes.49.6.975 · Cited by 361
Meigs, J. B., Muller, D. C., Nathan, D. M., Blake, D. R., & Andres, R. (2003) · Diabetes · doi:10.2337/diabetes.52.6.1475 · Cited by 338
Jensen, C. C., Cnop, M., Hull, R. L., Fujimoto, W. Y., Kahn, S. E., & the American Diabetes Association GENNID Study Group (2002) · Diabetes · doi:10.2337/diabetes.51.7.2170 · Cited by 312
Meyer, C., Pimenta, W., Woerle, H. J., Van Haeften, T., Szoke, E., Mitrakou, A., & Gerich, J. (2006) · Diabetes Care · doi:10.2337/dc06-0438 · Cited by 308
Weyer, C., Bogardus, C., & Pratley, R. E. (1999) · Diabetes · doi:10.2337/diabetes.48.11.2197 · Cited by 292
Hanefeld, M., Koehler, C., Fuecker, K., Henkel, E., Schaper, F., & Temelkova-Kurktschiev, T. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.868 · Cited by 238
Bock, G., Dalla Man, C., Campioni, M., Chittilapilly, E., Basu, R., Toffolo, G., Cobelli, C., & Rizza, R. (2006) · Diabetes · doi:10.2337/db06-0319 · Cited by 230
Self-citationUse of a novel triple-tracer approach to assess postprandial glucose metabolism
Basu, R., Di Camillo, B., Toffolo, G., Basu, A., Shah, P., Vella, A., Rizza, R., & Cobelli, C. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00190.2001 · Cited by 189
Self-citationBasu, R., Chandramouli, V., Dicke, B., Landau, B., & Rizza, R. (2005) · Diabetes · doi:10.2337/diabetes.54.7.1942 · Cited by 189
Self-citationBasu, A., Basu, R., Shah, P., Vella, A., Johnson, C. M., Jensen, M., Nair, K. S., Schwenk, W. F., & Rizza, R. A. (2001) · Diabetes · doi:10.2337/diabetes.50.6.1351 · Cited by 167
Self-citationBock, G., Chittilapilly, E., Basu, R., Toffolo, G., Cobelli, C., Chandramouli, V., Landau, B. R., & Rizza, R. A. (2007) · Diabetes · doi:10.2337/db06-1776 · Cited by 146
Self-citationFerrannini, E., Gastaldelli, A., Miyazaki, Y., Matsuda, M., Pettiti, M., Natali, A., Mari, A., & DeFronzo, R. A. (2003) · Diabetologia · doi:10.1007/s00125-003-1169-6 · Cited by 133
Effects of Changing Diagnostic Criteria on the Risk of Developing Diabetes
Dinneen, S. F., Maldonado, D., Leibson, C. L., Klee, G. G., Li, H., Melton, L. J., & Rizza, R. A. (1998) · Diabetes Care · doi:10.2337/diacare.21.9.1408 · Cited by 117
Self-citationMolecular Characterization of Insulin-Mediated Suppression of Hepatic Glucose Production In Vivo
Ramnanan, C. J., Edgerton, D. S., Rivera, N., Irimia-Dominguez, J., Farmer, B., Neal, D. W., Lautz, M., Donahue, E. P., Meyer, C. M., Roach, P. J., et al. (2010) · Diabetes · doi:10.2337/db09-1625 · Cited by 106
Utzschneider, K. M., Prigeon, R. L., Carr, D. B., Hull, R. L., Tong, J., Shofer, J. B., Retzlaff, B. M., Knopp, R. H., & Kahn, S. E. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1963 · Cited by 92
Basu, R., Schwenk, W. F., & Rizza, R. A. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00549.2003 · Cited by 87
Self-citationJones, J. G., Fagulha, A., Barosa, C., Bastos, M., Barros, L. M., Baptista, C. F., Caldeira, M. M., & Carvalheiro, M. C. (2006) · Diabetes · doi:10.2337/db06-0304 · Cited by 41
Self-citationPerreault, L., Bergman, B. C., Playdon, M. C., Dalla Man, C., Cobelli, C., & Eckel, R. H. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90354.2008 · Cited by 40
Jones, J. G., Barosa, C., Coreta-Gomes, F. M., Mendes, A. C., Delgado, T. C., Diogo, L. M., Garcia, P., Bastos, M., Barros, L. M., Fagulha, A., et al. (2006) · Journal of Carbohydrate Chemistry · doi:10.1080/07328300600732840 · Cited by 36
Self-citationBock, G., Schumann, W. C., Basu, R., Burgess, S. C., Yan, Z., Chandramouli, V., Rizza, R. A., & Landau, B. R. (2008) · Diabetes · doi:10.2337/db07-0694 · Cited by 32
Self-citationTransaldolase exchange and its effects on measurements of gluconeogenesis in humans
Basu, R., Barosa, C., Basu, A., Pattan, V., Saad, A., Jones, J. G., & Rizza, R. A. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00403.2010 · Cited by 15
Self-citationBasu, R., Chandramouli, V., Schumann, W. C., Basu, A., Landau, B. R., & Rizza, R. A. (2009) · Diabetes · doi:10.2337/db08-1300 · Cited by 13
Self-citation
Cited by
Reed, J., Bain, S., & Kanamarlapudi, V. (2021) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s319895 · Cited by 441
Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver
Satapati, S., Kucejova, B., Duarte, J. A. G., Fletcher, J. A., Reynolds, L., Sunny, N. E., He, T., Nair, L. A., Livingston, K., Fu, X., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci82204 · Cited by 399
Cichosz, S. L., Kronborg, T., Laugesen, E., Hangaard, S., Fleischer, J., Hansen, T. K., Jensen, M. H., Poulsen, P. L., & Vestergaard, P. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0226 · Cited by 223
Brannick, B., Wynn, A., & Dagogo-Jack, S. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216654227 · Cited by 177
Alkhalidy, H., Moore, W., Wang, A., Luo, J., McMillan, R. P., Wang, Y., Wei, Z. C., Hulver, M. W., & Liu, D. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.04.014 · Cited by 156
Metadata
- Authors
- Basu, R., Barosa, C., Jones, J., Dube, S., Carter, R., Basu, A., & Rizza, R. A.
- Affiliations
- Endocrine Research Unit, Division of Endocrinology, Diabetes, Metabolism, and Nutrition (R.B., S.D., A.B., R.A.R.), Rochester, Minnesota 55905
- University of Coimbra (PT)
- Mayo Clinic (US)
- Corresponding author
- Basu, Rita
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2013-03-01
- Volume
- 98
- Issue
- 3
- Pages
- E409-E417
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC3590488
- OpenAlex
- W2029696243
- Cited by
- 121
- References
- 25
- Citations by year
- 2026: 4 · 2025: 13 · 2024: 12 · 2023: 7 · 2022: 5 · 2021: 12 · 2020: 13 · 2019: 8 · 2018: 8 · 2017: 8 · 2016: 9 · 2015: 6 · 2014: 8 · 2013: 8
- FWCI
- 10.18
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Mayo Clinic
- National Institutes of Health (UL1TR000135)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK029953, P30DK050456, DK50456, DK 29953, R37DK029953)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- prediabetes, fasting hyperglycemia, postprandial hyperglycemia, hepatic glucose production, gluconeogenesis, glycogenolysis, glucose disappearance, insulin resistance, impaired fasting glucose, impaired glucose tolerance, hyperinsulinemic-euglycemic clamp, type 2 diabetes pathogenesis, liver
- MeSH terms
- Adult, Aged, Blood Glucose, C-Peptide, Carbon Isotopes, Diabetes Mellitus, Type 2, Fasting, Female, Glucagon, Gluconeogenesis, Humans, Hyperglycemia, Hyperinsulinism, Insulin, Liver, Male, Middle Aged, Prediabetic State, Glucose Clamp Technique, Glucose Intolerance, Glycogenolysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.